Method of treating lung cancer
AssigneeMacau University of Science and Technology
InventorsXiao Jun Yao, Lai Han Elaine Leung, Liang Liu, Xing Xing Fan, Chun Xie
Life of this patent
Estimating the term…
Abstract
One example embodiment relates to a method of treating non-small cell lung cancer by administering a compound of formula (I) to a patient. Another example embodiment relates to a method of inhibiting progress of tumor growth in a patient with cancer, wherein tumor cells of the cancer have a mutant V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) gene, and the method includes administering to the patient the compound with the following formula I:
Claims20
A method of treating non-small cell lung cancer (NSCLC) in a patient, comprising:
- administering a therapeutically effective amount of a compound to the patient to treat the NSCLC,
- wherein the compound is represented by formula I
A method of treating lung adenocarcinoma in a patient, comprising:
- administering a therapeutically effective amount of a compound to the patient to treat the lung adenocarcinoma,
- wherein the compound is represented by the formula I
A method of inhibiting progress of tumor growth in a patient with cancer, comprising:
- diagnosing the patient with the cancer when the presence of a mutation of V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) in cancer cells is detected;
- and
- administering a compound to the patient with the cancer to inhibit the progress of tumor growth,
- wherein the compound is represented by formula I
Dependencies are inferred from the claim text.